Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.46
+0.14 (1.50%)
Feb 27, 2026, 9:39 AM EST - Market open

Vir Biotechnology Revenue

In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%. Vir Biotechnology had revenue of $64.07M in the quarter ending December 31, 2025, with 417.78% growth.

Revenue (ttm)
$68.56M
Revenue Growth
-7.61%
P/S Ratio
21.37
Revenue / Employee
$186,801
Employees
367
Market Cap
1.49B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Monte Rosa Therapeutics181.54M
EyePoint42.34M
Septerna22.05M
uniQure15.75M
Zenas BioPharma15.00M
Capricor Therapeutics11.13M
Precigen6.31M
Revenue Rankings